Anti-proliferative effect of an aqueous extract of Prunella vulgaris in vascular smooth muscle cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Hwang, Sun Mi ^a,b   Lee, Yun Jung ^a,c   Lee, Yong Pyo ^a,c   Yoon, Jung Joo ^a,c   Lee, So Min ^a,c   Cha, Jeong Dan ^d   Choi, Kyung Min ^d   Kang, Dae Gill ^a,c   Lee, Ho Sub ^a,c  

^a Wonkwang University   (South Korea)

^b Korea Research Institute of Standards and Science   (South Korea)

^c Wonkwang University   (South Korea)

^d Institute of Jinan Red Ginseng   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GELATINASE A; GELATINASE B; GLUCOSE; HEME OXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PRUNELLA VULGARIS EXTRACT; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; VASCULAR SMOOTH MUSCLE; ZYMOGRAPHY;

EID: 84885334067     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/936463     Document Type: Article

References (44)

1. Dzau V. J., Braun-Dullaeus R. C., Sedding D. G., Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nature Medicine 2002 8 11 1249 1256 2-s2.0-0036851826 10.1038/nm1102-1249 (Pubitemid 35373556)
2. Bornfeldt K. E., Tabas I., Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metabolism 2011 14 5 575 585 2-s2.0-80455128548 10.1016/j.cmet.2011.07.015
3. Kim J. E., Choi H. C., Losartan inhibits vascular smooth muscle cell proliferation through activation of AMP-activated protein kinase. Korean Journal of Physiology and Pharmacology 2010 14 5 299 304 2-s2.0-78649367703 10.4196/kjpp.2010.14.5.299
4. Bond M., Sala-Newby G. B., Wu Y.-J., Newby A. C., Biphasic effect of p21cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation. Cardiovascular Research 2006 69 1 198 206 2-s2.0-29244441713 10.1016/j.cardiores.2005.08.020 (Pubitemid 41818971)
5. Denicourt C., Dowdy S. F., Cip/Kip proteins: more than just CDKs inhibitors. Genes and Development 2004 18 8 851 855 2-s2.0-1942434712 10.1101/gad.1205304 (Pubitemid 38529654)
6. Zhan Y., Kim S., Izumi Y., Izumiya Y., Nakao T., Miyazaki H., Iwao H., Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 5 795 801 2-s2.0-0037625636 10.1161/01.ATV.0000066132. 32063.F2 (Pubitemid 36566168)
7. Zhu L., Sun G., Zhang H., Zhang Y., Chen X., Jiang X., Jiang X., Krauss S., Zhang J., Xiang Y., Zhang C.-Y., PGC-1 α is a key regulator of glucose-induced proliferation and migration in vascular smooth muscle cells. PLoS ONE 2009 4 1 2-s2.0-58449132292 10.1371/journal.pone.0004182 e4182
8. Cho A., Reidy M. A., Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circulation Research 2002 91 9 845 851 2-s2.0-0036843534 10.1161/01.RES.0000040420.17366.2E (Pubitemid 35285083)
9. Death A. K., Fisher E. J., McGrath K. C. Y., Yue D. K., High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis 2003 168 2 263 269 2-s2.0-0038173265 10.1016/S0021-9150(03)00140-0 (Pubitemid 36703325)
10. Signorelli S. S., Malaponte G., Libra M., Di Pino L., Celotta G., Bevelacqua V., Petrina M., Nicotra G. S., Indelicato M., Navolanic P. M., Pennisi G., Mazzarino M. C., Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease. Vascular Medicine 2005 10 1 1 6 2-s2.0-20844448886 10.1191/ 1358863x05vm582oa (Pubitemid 40667579)
11. Deschamps A. M., Spinale F. G., Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovascular Research 2006 69 3 666 676 2-s2.0-31344466167 10.1016/j.cardiores.2005.10.004 (Pubitemid 43139729)
12. Aggarwal B. B., Nuclear factor- B: the enemy within. Cancer Cell 2004 6 3 203 208 2-s2.0-4544342570 10.1016/j.ccr.2004.09.003 (Pubitemid 39222032)
13. Idriss N. K., Blann A. D., Lip G. Y. H., Hemoxygenase-1 in cardiovascular disease. Journal of the American College of Cardiology 2008 52 12 971 978 2-s2.0-50949108524 10.1016/j.jacc.2008.06.019
14. Pae H.-O., Lee Y. C., Chung H.-T., Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. Recent Patents on Inflammation and Allergy Drug Discovery 2008 2 3 159 165 2-s2.0-61449417240
15. Kinderlerer A. R., Gregoire I. P., Hamdulay S. S., Ali F., Steinberg R., Silva G., Ali N., Wang B., Haskard D. O., Soares M. P., Mason J. C., Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin. Blood 2009 113 7 1598 1607 2-s2.0-61849124659 10.1182/blood-2008-04-152934
16. Yu Z.-W., Li D., Ling W.-H., Jin T.-R., Role of nuclear factor (erythroid-derived 2)-like 2 in metabolic homeostasis and insulin action: a novel opportunity for diabetes treatment? World Journal of Diabetes 2012 15 19 28
17. Jung K.-A., Kwak M.-K., The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 2010 15 10 7266 7291 2-s2.0-78149434112 10.3390/molecules15107266
18. Zhu Y.-P., Chinese material medica-chemistry, pharmacology and application. Phytochemistry 2000 54 111 112
19. Hwang S. M., Kim J. S., Lee Y. J., Anti-diabetic atherosclerosis effect of Prunella vulgaris in db/db mice with type 2 diabetes. American Journal of Chinese Medicine 2012 50 937 951
20. Zheng J., He J., Ji B., Li Y., Zhang X., Antihyperglycemic activity of Prunella vulgaris L. in streptozotocin-induced diabetic mice. Asia Pacific Journal of Clinical Nutrition 2007 16 1 427 431 2-s2.0-34047123789 (Pubitemid 46524639)
21. Hwang S. M., Lee Y. J., Yoon J. J., Lee S. M., Kim J. S., Kang D. G., Lee H. S., Prunella vulgaris suppresses HG-induced vascular inflammation via Nrf2/HO-1/eNOS activation. International Journal of Molecular Sciences 2012 13 1 1258 1268 2-s2.0-84856283520 10.3390/ijms13011258
22. Hwang S. M., Lee Y. J., Yoon J. J., Lee S. M., Kang D. G., Lee H. S., Gardenia jasminoides inhibits tumor necrosis factor-alpha-induced vascular inflammation in endothelial cells. Phytotherapy Research 2010 24 2 S214 S219 2-s2.0-77953901387 10.1002/ptr.3099
23. Kim T.-J., Han H.-J., Hong S.-S., Hwang J.-H., Hwang B.-Y., Yoo H.-S., Jin Y.-R., Lee J.-J., Yu J.-Y., Lee K.-H., Kang B.-W., Yun Y.-P., Cudratricusxanthone A isolated from the root bark of Cudrania tricuspidata inhibits the proliferation of vascular smooth muscle cells through the suppression of PDGF-receptor beta tyrosine kinase. Biological and Pharmaceutical Bulletin 2007 30 4 805 809 2-s2.0-34147126558 10.1248/bpb.30.805 (Pubitemid 46570995)
24. Ramos-DeSimone N., Hahn-Dantona E., Sipley J., Nagase H., French D. L., Quigley J. P., Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. Journal of Biological Chemistry 1999 274 19 13066 13076 2-s2.0-0033532205 10.1074/jbc.274.19.13066 (Pubitemid 29220428)
25. Lee S.-O., Chang Y.-C., Whang K., Kim C.-H., Lee I.-S., Role of NAD(P)H:quinone oxidoreductase 1 on tumor necrosis factor- α -induced migration of human vascular smooth muscle cells. Cardiovascular Research 2007 76 2 331 339 2-s2.0-36649021571 10.1016/j.cardiores.2007.06.030 (Pubitemid 350198593)
26. Moon S.-K., Cho S.-H., Kim K.-W., Jeon J. H., Ko J.-H., Kim B. Y., Kim C.-H., Overexpression of membrane sialic acid-specific sialidase Neu3 inhibits matrix metalloproteinase-9 expression in vascular smooth muscle cells. Biochemical and Biophysical Research Communications 2007 356 3 542 547 2-s2.0-33947654342 10.1016/j.bbrc.2007.02.155 (Pubitemid 46499001)
27. Kim S. Z., Kim S. H., Park J. K., Koh G. Y., Cho K. W., Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum. Journal of Urology 1998 159 5 1741 1746 2-s2.0-0345490846 (Pubitemid 29117394)
28. Ross R., Atherosclerosis-an inflammatory disease. New England Journal of Medicine 1999 340 2 115 126 2-s2.0-0033552883 10.1056/NEJM199901143400207 (Pubitemid 29054847)
29. Newby A. C., Zaltsman A. B., Molecular mechanisms in intimal hyperplasia. Journal of Pathology 2000 190 300 309 (Pubitemid 30141376)
30. Yang J.-G., Shen Y.-H., Hong Y., Jin F.-H., Zhao S.-H., Wang M.-C., Shi X.-J., Fang X.-X., Stir-baked Fructus gardeniae (L.) extracts inhibit matrix metalloproteinases and alter cell morphology. Journal of Ethnopharmacology 2008 117 2 285 289 2-s2.0-41949128617 10.1016/j.jep.2008.01.033
31. Lee Y. J., Kim J. S., Kang D. G., Lee H. S., Buddleja officinalis suppresses high glucose-induced vascular smooth muscle cell proliferation: role of mitogen-activated protein kinases, nuclear factor- B and matrix metalloproteinases. Experimental Biology and Medicine 2010 235 2 247 255 2-s2.0-77649152285 10.1258/ebm.2009.009222
32. Hwang Y. P., Yun H. J., Kim H. G., Han E. H., Lee G. W., Jeong H. G., Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKC α /Raf/MAPKs and NF- B/AP-1-dependent mechanisms. Biochemical Pharmacology 2010 79 12 1714 1726 2-s2.0-77951298166 10.1016/j.bcp.2010.02.003
33. Kang M. J., Xiaoyan W., Hao L., Thai K., Scholey J. W., Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic glomeruli. Kidney International 1999 55 6 2203 2214 2-s2.0-0032989227 10.1046/j.1523-1755.1999.00488.x (Pubitemid 29256475)
34. Jia H., Qi X., Fang S., Jin Y., Han X., Wang Y., Wang A., Zhou H., Carnosine inhibits high glucose-induced mesangial cell proliferation through mediating cell cycle progression. Regulatory Peptides 2009 154 1-3 69 76 2-s2.0-63049101104 10.1016/j.regpep.2008.12.004
35. Li H. L., Peng W. H., Zhuang J. H., Vaspin attenuates high glucose-induced vascular smooth muscle cells proliferation and chemokinesis by inhibiting the MAPK, PI3K/Akt, and NF-kB signaling pathways. Atherosclerosis 2013 228 61 68
36. Giacco F., Brownlee M., Oxidative stress and diabetic complications. Circulation Research 2010 107 9 1058 1070 2-s2.0-78349297565 10.1161/CIRCRESAHA.110.223545
37. Lee S.-O., Jeong Y.-J., Yu M. H., Lee J.-W., Hwangbo M. H., Kim C.-H., Lee I.-S., Wogonin suppresses TNF- α -induced MMP-9 expression by blocking the NF- B activation via MAPK signaling pathways in human aortic smooth muscle cells. Biochemical and Biophysical Research Communications 2006 351 1 118 125 2-s2.0-33750331488 10.1016/j.bbrc.2006.10.006 (Pubitemid 44635415)
38. Uemura S., Matsushita H., Li W., Glassford A. J., Asagami T., Lee K.-H., Harrison D. G., Tsao P. S., Diabetes mellitus enhances vascular matrix metalloproteinase activity role of oxidative stress. Circulation Research 2001 88 12 1291 1298 2-s2.0-0035933381 (Pubitemid 32587846)
39. Inoguchi T., Nawata H., NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive β -cell dysfunction and metabolic syndrome. Current Drug Targets 2005 6 4 495 501 2-s2.0-21444439103 10.2174/1389450054021927 (Pubitemid 40916274)
40. Brunt K. R., Tsuji M. R., Lai J. H., Kinobe R. T., Durante W., Claycomb W. C., Ward C. A., Melo L. G., Heme oxygenase-1 inhibits pro-oxidant induced hypertrophy in HL-1 cardiomyocytes. Experimental Biology and Medicine 2009 234 5 582 594 2-s2.0-66149108051 10.3181/0810-RM-312
41. Rushworth S. A., MacEwan D. J., The role of Nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cells. Cancers 2011 3 2 1605 1621 2-s2.0-79959693771 10.3390/cancers3021605
42. Rizzo N. O., Maloney E., Pham M., Luttrell I., Wessells H., Tateya S., Daum G., Handa P., Schwartz M. W., Kim F., Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 4 758 765 2-s2.0-77950909714 10.1161/ATVBAHA.109.199893
43. Cui X., Chopp M., Zacharek A., Zhang C., Roberts C., Chen J., Role of endothelial nitric oxide synthetase in arteriogenesis after stroke in mice. Neuroscience 2009 159 2 744 750 2-s2.0-60849129100 10.1016/j.neuroscience.2008. 12.055
44. Pae H.-O., Oh G.-S., Choi B.-M., Kim Y.-M., Chung H.-T., A molecular cascade showing nitric oxide-heme oxygenase-1-vascular endothelial growth factor-interleukin-8 sequence in human endothelial cells. Endocrinology 2005 146 5 2229 2238 2-s2.0-17744385995 10.1210/en.2004-1431 (Pubitemid 40577510)